Taranjeet Jolly

In this commentary, the authors discuss the potential interactions of opioid use disorder treatments with novel COVID-19 medications.

The FDA has approved remdesivir for severe COVID-19 in children and adults. This commentary reviews potential interactions of remdesivir with psychotropic medications.

In this commentary, the authors discuss the potential interactions of ritonavir/lopinavir with psychiatric medications in the context of COVID-19.

In this letter to the editor, the authors reply to Kow and Hasan.

The relationship between INF-β and depression and suicidality has not been strongly established. Here, read about a woman with multiple sclerosis with new-onset depression who was taking fluoxetine in...